SCHEMBL9050898

SCHEMBL9050898

COC(OC)[C@@H]1CSCN1C(=O)[C@@H]1CCCN1C(=O)CCC1Cc2ccccc2C1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PREP P48147 19/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9046409 0.96 PREP (0.59) PREP
SCHEMBL9048094 0.96 PREP (0.59) PREP
SCHEMBL9048384 0.91 PREP (0.55) PREP
SCHEMBL9047969 0.91 PREP (0.64) PREP
SCHEMBL9047612 0.89 PREP (0.58) PREP
SCHEMBL9047607 0.89 PREP (0.58) PREP
SCHEMBL9050518 0.88 PREP (0.62) PREP
SCHEMBL9050519 0.88 PREP (0.62) PREP
SCHEMBL9048627 0.87 PREP (0.51) PREP
SCHEMBL9048021 0.87 PREP (0.51) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed